NextCure Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: NextCure Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Baltimore
Headquarters state / province: Maryland
Headquarters country: United States
Fiscal year end: December
Ticker symbol: NXTC
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001661059
EIN: 47-5231247

Board of directors

Follow this board

Anne Elizabeth Borgman · Director
Since 2023
Chau Quang Khuong · Director
Since 2023
David S. Kabakoff · Director
Since 2023
Elaine Jones V · Director
Since 2023
Ellen Feigal · Director
Since 2023
Garry A. Nicholson · Director
Since 2023
John G. Houston · Director
Since 2023
Michael Richman · Director · President & CEO
Since 2023
Stephen W. Webster · Director
Since 2023

Chief executives

Michael Richman · President & CEO

Dates unknown

Director election results

Annual meeting of June 22, 2023. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 9 other boards. 9 are in the same sector.

Shared director Other board Same sector

Arvinas Inc. Same sector
via John G. Houston
Cullinan Therapeutics Inc. Same sector
via Stephen W. Webster
Curis Inc. Same sector
via Anne Elizabeth Borgman
CytomX Therapeutics Inc. Same sector
via Elaine Jones V
Damora Therapeutics Inc. Same sector
via Chau Quang Khuong
Eloxx Pharmaceuticals Inc. Same sector
via Stephen W. Webster
Palvella Therapeutics Inc. Same sector
via Michael Richman
TScan Therapeutics Inc. Same sector
via Garry A. Nicholson
Xencor Inc. Same sector
via Ellen Feigal

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $1,789,544; 18 purchases by 1 insider
Sold, last 12 months: $184,800; 1 sale by 1 insider

Date	Insider	Transaction	Shares	Price	Value
Nov 6, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+3,662	$5.10	$18,676
Nov 5, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+1,024	$5.10	$5,222
Oct 27, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+3,553	$5.10	$18,104
Oct 26, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+1,672	$5.03	$8,418
Oct 23, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+5,626	$4.83	$27,170
Aug 10, 2026	Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. Former 10% Owner	Open-market sale	−30,000	$6.16	$184,800
Jul 31, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+3,300	$4.98	$16,434
Jul 31, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+25,000	$4.98	$124,500
Jul 31, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+8,003	$4.80	$38,414
Jul 30, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+50,000	$4.97	$248,500
Jul 30, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+20,000	$5.00	$100,000
Jul 30, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+20,000	$5.00	$100,000
Jul 30, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+25,000	$4.81	$120,250
Jul 30, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+100,000	$4.90	$490,000
Jul 30, 2026	ADAR1 Capital Management, LLC 10% owner	Open-market purchase	+77,850	$4.96	$386,136

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about NextCure Inc.

Who is the CEO of NextCure Inc.?

Michael Richman is NextCure Inc.'s President & CEO.

How many directors are on NextCure Inc.'s board?

NextCure Inc.'s board has 9 directors: Anne Elizabeth Borgman, Chau Quang Khuong, David S. Kabakoff, Elaine Jones V, Ellen Feigal, Garry A. Nicholson, John G. Houston, Michael Richman and Stephen W. Webster.

Are NextCure Inc. insiders buying or selling shares?

Over the last 12 months, NextCure Inc. insiders bought $1.8 million of shares in 18 purchases and sold $184,800 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.

How is NextCure Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="nextcure-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.